Association of Celiac Disease and Plasminogen Activator Inhibitor-1 Polymorphism
Öz
Objective: Celiac disease (CD) is an autoimmune disease. Although susceptibility to thrombosis in celiac patients has been reported in case studies, the cause is not yet known. PAI-1 inhibits fibrinolysis. In this study, the association between celiac disease and PAI-1 4G/5G polymorphism was investigated among celiac patients whose disease were confirmed by intestinal biopsy and healthy controls.
Methods: Biopsy-diagnosed celiac patients (n=56) and healthy controls (n=52) were included in the study. PCR-RFLP method was used for PAI-1 genotyping and the results were compared according to statistical significance.
Results: The PAI-1 4G allele associated with thrombotic risk and inflammation was found to be higher than the 5G allele in cases (0.63 and 0.36, respectively, p=0.054). When the age at diagnosis was compared according to the PAI-1 variants, no significant difference was found (p=0.3). Although the genotype frequencies were similar in 4G/4G patients and controls, the 5G/5G genotype, known as the protective genotype, was found to be higher in controls (35% and 18%).
Conclusion: In our study, the 4G allele of PAI-1, which plays a role in the susceptibility to thrombosis, was observed more frequently in celiac patients compared to the control group. Studying genetic markers of thrombosis in celiac patients is important for individual prophylaxis.
Anahtar Kelimeler
Celiac disease, Plasminogen Activator Inhibitor 1, Polymorphizm, Thrombosis
Destekleyen Kurum
Acıbadem Mehmet Ali Aydınlar University
Proje Numarası
ABAPKO Decision Number :2017/01/06.
Kaynakça
- Referans1 Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002;346(03):180–88.
- Referans2 Gujral N, Freeman HJ, Thomson ABR. Celiac disease: Prevalence, diagnosis, pathogenesis and treatment World J Gastroenterol. 2012;18(42):6036–59.
- Referans3 ESPGN Group: Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990;65:909-11
- Referans4 Ghannouchi Jaafoura N, Atig A, Bouker A, Alaoua O, Ben Jazia E, Khalifa M, Bahri F. Intracardiac thrombosis during celiac disease. J Mal Vasc. 2014;39(3):203-6.
- Referans5 Lerner A, Blank M. Hypercoagulability in celiac disease--an update. Autoimmun Rev. 2014;13(11):1138-41.
- Referans6 Agirbasli M. Pivotal role of plasminogen-activator inhibitor 1 in vascular disease. Int J Clin Pract 2005;59(1):102-6.
- Referans7 Flevaris P, Vaughan D.The Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis. Semin Thromb Hemost. 2017;43(2):169-77.
- Referans8 Wang ZH, Ren WY, Zhu L, Hu LJ. Plasminogen activator inhibitor-1 regulates LPS induced inflammation in rat macrophages through autophagy activation. Sci World J. 2014;2014:189168.
- Referans9 Pham BT, van Haaften WT, Oosterhuis D, Nieken J, de Graaf IA, Olinga P. Precision-cut rat, mouse, and human intestinal slices as novel models for the early-onset of intestinal fibrosis. Physiol Rep. 2015;3(4). pii: e12323
- Referans10 Eriksson P, Kallin B, van 't Hooft F M, Båvenholm P, and Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A. 1995;92(6):1851–55.